Boswellia

Phase 1Small molecule

MMansoura University

Boswellia is one of 40 small molecule programs targeting Periodontitis. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PeriodontitisActive, not recruiting

Breast CancerActive, not recruiting

PeriodontitisPhase 2/Phase 3

Active, not recruiting

Breast CancerPhase 1

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

DATROWAY

Daiichi Sankyo

Preclinical

4 2

Zolymbus

AbbVie

Preclinical

1 3

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

3 4

Acupan

YYonsei University

Preclinical

1 5

Chantix

PPrism Pharmaceuticals

Preclinical

1 6

Paracetamol

GSK

Preclinical

1 7

Motexafin Gadolinium

PPharmacyclics LLC.

Preclinical

1 8

Dextromethorphan Hydrobromide

Boehringer Ingelheim

Preclinical

1 9

Perflutren Lipid Microsphere

IImaRx Therapeutics

Preclinical

1 10

Boswellia

MMansoura University

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Breast Cancer1 trial

A "Window Trial" on Boswellia for Breast Cancer Primary Tumors

Completed·MMedical University of South Carolina·Phase 1·NCT03149081·46 enrolled

Periodontitis1 trial

Investigate"Clinically" the Effectiveness of Boswellia Based Intracanal Medication Compared to Calcium Hydroxide Ca(OH)2 and Ledermix on the Levels of Bacteria and Inflammatory Cytokines in Root Canals and Periradicular Tissues of Teeth With Apical Periodontitis

Recruiting·MMansoura University·Phase 2/3·NCT06466538·36 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Boswellia. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Boswellia compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Boswellia. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: MMansoura University

Boswellia

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Breast Cancer1 trial

Periodontitis1 trial

References

Drug Info

Quick Facts

Related News